Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NICE Updates Technology Appraisal Process, Issues Ablation Guidelines

This article was originally published in The Gray Sheet

Executive Summary

Manufacturer and sponsor guidelines on submitting evidence for National Institute for Clinical Excellence technology appraisals will be issued later this year, according to UK's health tech assessment organization

You may also be interested in...



International News In Brief

A European CDC?: EU Center for Disease Prevention & Control would be created under a proposal adopted by the European Commission July 23. Developed in response to the SARS outbreak, the initiative would enhance microbiological labs' quality assurance schemes. Pending passage through Parliament and Council, the agency could be in operation by 2005...

NICE Final Appraisal Guidance Expands Sponsor Participation, Timeline

The U.K. National Institute for Clinical Excellence final guidance on technology appraisals gives manufacturers more opportunity to define the scope of appraisals, while extending the timeline for the process to over one year.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020202

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel